about
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementExposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet.CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects.Optimal utilisation of sulphonylureas in resource-constrained settingsGlargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sulfonylureas: do we need to introspect safety again?
@en
Sulfonylureas: do we need to introspect safety again?
@nl
type
label
Sulfonylureas: do we need to introspect safety again?
@en
Sulfonylureas: do we need to introspect safety again?
@nl
prefLabel
Sulfonylureas: do we need to introspect safety again?
@en
Sulfonylureas: do we need to introspect safety again?
@nl
P2093
P2860
P1476
Sulfonylureas: do we need to introspect safety again?
@en
P2093
Devindra Sehra
Shiv Tej Sehra
Sudhish Sehra
P2860
P304
P356
10.1517/14740338.2011.583234
P407
P577
2011-05-23T00:00:00Z